TY - JOUR
T1 - HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1*03 haplotype
AU - Howson, J. M.M.
AU - Roy, M. S.
AU - Zeitels, L.
AU - Stevens, H.
AU - Todd, J. A.
PY - 2013/6
Y1 - 2013/6
N2 - Aims: Owing to strong linkage disequilibrium between markers, pinpointing disease associations within genetic regions is difficult in European ancestral populations, most notably the very strong association of the HLA-DRB1*03-DQA1*05:01-DQB1*02:01 haplotype with Type 1 diabetes risk, which is assumed to be because of a combination of HLA-DRB1 and HLA-DQB1. In contrast, populations of African ancestry have greater haplotype diversity, offering the possibility of narrowing down regions and strengthening support for a particular gene in a region being causal. We aimed to study the human leukocyte antigen (HLA) region in African American Type 1 diabetes. Methods: Two hundred and twenty-seven African American patients with Type 1 diabetes and 471 African American control subjects were tested for association at the HLA class II genes, HLA-DRB1, HLA-DQA1, HLA-DQB1 and 5147 single nucleotide polymorphisms across the major histocompatibility complex region using logistic regression models. Population admixture was accounted for with principal components analysis. Results: Single nucleotide polymorphism marker associations were explained by the HLA associations, with the major peak over the class II loci. The HLA association overall was extremely strong, as expected for Type 1 diabetes, even in African Americans in whom diabetes diagnosis is heterogeneous. In addition, there were unique features: the HLA-DRB1*03 haplotype was split into HLA-DRB1*03:01, which confers greatest susceptibility in these samples (odds ratio3.17, 95% CI 1.72-5.83) and HLA-DRB1*03:02, an allele rarely observed in Europeans, which confers the greatest protection in these African American samples (odds ratio 0.22, 95% CI 0.09-0.55). Conclusions: The unique diversity of the African HLA region we have uncovered supports a specific and major role for HLA-DRB1 in HLA-DRB1*03 haplotype-associated Type 1 diabetes risk. What's new?: This is the largest study in African Americans with Type 1 diabetes to date and the only study to account for ancestry. This is the only study to date that fine maps the HLA region in African American samples using a dense map of 5147 single nucleotide polymorphisms and the class II genes. We find HLA Type 1 diabetes associations that agree with known associations in Europeans, and novel associations of African ancestry specific alleles, e.g. HLA-DRB1*03:02, which confers protection from Type 1 diabetes.
AB - Aims: Owing to strong linkage disequilibrium between markers, pinpointing disease associations within genetic regions is difficult in European ancestral populations, most notably the very strong association of the HLA-DRB1*03-DQA1*05:01-DQB1*02:01 haplotype with Type 1 diabetes risk, which is assumed to be because of a combination of HLA-DRB1 and HLA-DQB1. In contrast, populations of African ancestry have greater haplotype diversity, offering the possibility of narrowing down regions and strengthening support for a particular gene in a region being causal. We aimed to study the human leukocyte antigen (HLA) region in African American Type 1 diabetes. Methods: Two hundred and twenty-seven African American patients with Type 1 diabetes and 471 African American control subjects were tested for association at the HLA class II genes, HLA-DRB1, HLA-DQA1, HLA-DQB1 and 5147 single nucleotide polymorphisms across the major histocompatibility complex region using logistic regression models. Population admixture was accounted for with principal components analysis. Results: Single nucleotide polymorphism marker associations were explained by the HLA associations, with the major peak over the class II loci. The HLA association overall was extremely strong, as expected for Type 1 diabetes, even in African Americans in whom diabetes diagnosis is heterogeneous. In addition, there were unique features: the HLA-DRB1*03 haplotype was split into HLA-DRB1*03:01, which confers greatest susceptibility in these samples (odds ratio3.17, 95% CI 1.72-5.83) and HLA-DRB1*03:02, an allele rarely observed in Europeans, which confers the greatest protection in these African American samples (odds ratio 0.22, 95% CI 0.09-0.55). Conclusions: The unique diversity of the African HLA region we have uncovered supports a specific and major role for HLA-DRB1 in HLA-DRB1*03 haplotype-associated Type 1 diabetes risk. What's new?: This is the largest study in African Americans with Type 1 diabetes to date and the only study to account for ancestry. This is the only study to date that fine maps the HLA region in African American samples using a dense map of 5147 single nucleotide polymorphisms and the class II genes. We find HLA Type 1 diabetes associations that agree with known associations in Europeans, and novel associations of African ancestry specific alleles, e.g. HLA-DRB1*03:02, which confers protection from Type 1 diabetes.
UR - http://www.scopus.com/inward/record.url?scp=84878063167&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878063167&partnerID=8YFLogxK
U2 - 10.1111/dme.12148
DO - 10.1111/dme.12148
M3 - Article
C2 - 23398374
AN - SCOPUS:84878063167
SN - 0742-3071
VL - 30
SP - 710
EP - 716
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 6
ER -